Enhanced recovery after cleft palate repair: A quality improvement project
- PMID: 35929340
- DOI: 10.1111/pan.14541
Enhanced recovery after cleft palate repair: A quality improvement project
Abstract
Background: Children undergoing cleft palate repair present challenges to postoperative management due to several factors that can complicate recovery. Utilization of multimodal analgesic protocols can improve outcomes in this population. We report experience designing and implementing an enhanced recovery after surgery (ERAS) pathway for cleft palate repair to optimize postoperative recovery.
Aims: The primary aim was to implement an ERAS pathway with >70% bundle adherence to achieve a 30% reduction in postoperative opioid consumption within 12 months. Our secondary aims assessed intraoperative opioid consumption, length of stay, timeliness of oral intake, and respiratory recovery.
Methods: A multidisciplinary team of perioperative providers developed an ERAS pathway for cleft palate patients. Key drivers included patient and provider education, formal pathway creation and implementation, multimodal pain therapy, and target-based care. Interventions included maxillary nerve blockade and enhanced intra- and postoperative medication regimens. Outcomes were displayed as statistical process control charts.
Results: Pathway compliance was 77.0%. Patients during the intervention period (n = 39) experienced a 49% reduction in postoperative opioid consumption (p < .0001) relative to our historical cohort (n = 63), with a mean difference of -0.33 ± 0.11 mg/kg (95% CI -0.55 to -0.12 mg/kg). Intraoperative opioid consumption was reduced by 36% (p = .002), with a mean difference of -0.27 ± 0.09 mg/kg (95% CI -0.45 to -0.09 mg/kg). Additionally, patients in the intervention group had a 45% reduction in time to first oral intake (p = .02) relative to our historical cohort, with a mean difference of -3.81 ± 1.56 h (95% CI -6.9 to -0.70). There was no difference in PACU or hospital length of stay, but there was a significant reduction in variance of all secondary outcomes.
Conclusion: Opioid reduction and improved timeliness of oral intake is possible with an ERAS protocol for cleft palate repair, but our protocol did not alter PACU or hospital length of stay.
Keywords: analgesics-opioid; cleft palate; enhanced recovery after surgery; length of stay; maxillary nerve; pain-postoperative.
© 2022 John Wiley & Sons Ltd.
References
REFERENCES
-
- Doyle E, Hudson I. Anaesthesia for primary repair of cleft lip and cleft palate: a review of 244 procedures. Pediatr Anesth. 1992;2(2):139-145.
-
- Kulkarni K, Patil M, Shirke A, Jadhav S. Perioperative respiratory complications in cleft lip and palate repairs: an audit of 1000 cases under ′Smile Train Project. Indian J Anaesth. 2013;57(6):562-568.
-
- Rossell-Perry P, Romero-Narvaez C, Rojas-Sandoval R, Gomez-Henao P, Delgado-Jimenez MP, Marca-Ticona R. Is the use of opioids safe after primary cleft palate repair? a systematic review. Plast Reconstr Surg Glob Open. 2021;9(1):e3355.
-
- Brindle ME, Heiss K, Scott MJ, et al. Embracing change: the era for pediatric ERAS is here. Pediatr Surg Int. 2019;35(6):631-634.
-
- Hush SE, Chen JT, Brady CM, et al. Implementation of a modified enhanced recovery protocol in cleft palate repairs. J Craniofac Surg. 2019;30(7):2154-2158.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
